References

  1. The Leading Edge Research, August 2005.
  2. Eden Survey : Proceedings from the National Conference of Asociación Española de Pediatría, 20 June 2003; Madrid Spain.
  3. Xinias I et al. Cornstarch thickened formula reduces oesophageal acid exposure time in infants. Digestive and Liver Disease 2005; 37: 23-27.
  4. Le Luyer B et al. Intestinal transit in infants: Comparison of the impact of two infant formulae.Exerpts from “Revue Internationale De Pediatrie,”  2002; XXXIII (316): 5-8.
  5. Girardet JP, Palier G.  Clinical trial of an anti-diarrheal diet : Novalac AD. Exerpts from “Revue Internationale De Pediatrie,”  2001 ;XXXII (309) :45-8.
  6. Allen KJ et al. Food Allergy in Childhood. MJA 2006; 185(7); 394-400.
  7. Study presented at 4th Interactives days of Paediatric Reality – France, 28/03/03
  8. Vandenplas Y et al. Dietary treatment for regurgitation--recommendations from a working party.Acta Paediatr, 1998; 87(4): 462-468.
  9. NHMRC: Dietary Guidelines for Children and Adolescents in Australia, Incorporating Infant Feeding Guidelines for Health Workers.  Endorsed 10 April 2003.
  10. Sferra TJ, Heitlinger LA.  Gastrointestinal Gas Formation and Infantile Colic. Paediatr Clin North America, 1996; 43(2): 489-509.
  11. Stagnara J et al. Clinical data on the diagnosis of colic in infants. Survey in 2,773 infants aged 15-119 days. Arch Paediatr, 1997; 4: 959-966.
  12. Treem WR. Infant Colic. A Paediatric Gastroenterologist’s Perspective. Pediatr Clin North Am 1994; 41(5): 1121-1137.
Bayer Healthcare
Intended for an Australian and New Zealand audience only. Novalac is a registered trademark.